Gilead and Aelix first teamed up in 2018 for a clinical research collaboration agreement to investigate the vaccine.

Kelun-Biotech’s TROP2 ADC sacituzumab tirumotecan receives China NMPA marketing approval for 2L+ advanced or metastatic TNBC: Chengdu Thursday, November 28, 2024, 10:00 Hrs [IST ...

Earlier this year, entrepreneur and women’s health advocate Sheila Mikhail received the Triangle Business Journal’s Lifetime ...

Mizuho's Jared Holz joins 'Fast Money' to talk what's next for biopharma space after president-elect Trump names his pick for ...

The University of Kansas is working with biotechnology lab Design-Zyme to produce vaccines for both Lyme disease and Chlamydia.

A cancer treatment similar to sac-TMT approved for marketing in China is Trodelvy (sacituzumab govitecan-hziy), developed by ...

Things took a worse turn after this as my daughter started shaking involuntarily. Since then, my daughter has been paralysed ...

North Wales Police said he was in a remote location above Maenan in the Conwy valley in Conwy county. America's Federal ...

US President-elect Donald Trump’s list of cabinet picks expanded rapidly over the weekend with the former star of The ...

This month, Trump created a new unofficial Department of Government Efficiency led by billionaire Tesla CEO Elon Musk and ...

Authorities say a suspect wanted in the U.S. for two bombings in the San Francisco area in 2003 has appeared in a London ...